Skip to main navigation Skip to search Skip to main content

Clinical and experimental studies on colorectal peritoneal metastases

  • Paulien Rauwerdink

Research output: Thesis › Doctoral thesis 1 (Research UU / Graduation UU)

Abstract

Colorectal cancer (CRC) affects approximately 14,000 patients annually in the Netherlands. Up to half of these patients develop distant metastases, including peritoneal metastases. Patients with limited colorectal peritoneal metastases (CPM) may undergo potentially curative cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC). However, approximately 60% of patients with CPM present with unresectable disease, leaving palliative systemic therapy as the primary treatment option, with poor survival outcomes. This thesis investigates different treatment strategies for both unresectable and resectable CPM.

The first part evaluates pressurized intraperitoneal aerosol chemotherapy (PIPAC) combined with systemic therapy in patients with unresectable CPM. In the CRC-PIPAC-II study, 20 patients underwent 52 cycles of this bidirectional treatment. Moderate complications occurred in seven patients (35%), without treatment-related mortality. Although no radiological responses were observed, pathological, cytological, and biochemical responses was observed in 88%, 38%, and 31% of evaluable patients, respectively. Two patients subsequently underwent CRS-HIPEC. Median progression-free and overall survival were 10.0 and 17.5 months, respectively. These findings demonstrate the feasibility and relative safety of bidirectional treatment.

Pharmacokinetic analyses revealed that nearly half of the intraperitoneally administered oxaliplatin reached the systemic circulation, challenging the assumption that PIPAC is exclusively a locoregional treatment. These findings have implications for chemotherapy dosing and toxicity management. Despite treatment-related adverse events, patient-reported outcomes demonstrated largely preserved quality of life and daily functioning, with only transient increases in abdominal and general pain.

The second part focuses on optimizing surgical treatment and understanding the biology of specific sites of peritoneal metastases. Molecular and immunohistochemical analyses demonstrated that ovarian metastases from CRC exhibit an immune-cold microenvironment, with increased progesterone receptor expression. In experimental models, progesterone inhibition with mifepristone increased immune infiltration and reduced liver metastases, suggesting a potential therapeutic strategy.

Furthermore, a study evaluating selective removal of macroscopically visible omental metastases as an alternative to routine omentectomy during CRS-HIPEC demonstrated that approximately 20% of these metastases remained undetected intraoperatively. These findings suggest that omentum preservation cannot currently be considered a reliable surgical approach under current conditions.

Finally, a retrospective cohort study of patients with pseudomyxoma peritonei (PMP) revealed discordant histopathological grading between primary appendiceal tumors and peritoneal deposits in 13% of patients, supporting the need for separate histopathological classification. Disease recurrence occurred in 32% of patients, generally without changes in histological subtype. An additional case report described an unusual intraluminal recurrence of PMP in the small bowel.

In conclusion, this thesis provides new insights into the safety, feasibility, pharmacokinetics, and patient-reported outcomes of PIPAC-based treatment, as well as the biological mechanisms underlying metastases and the surgical management of CPM. Together, these findings contribute to the optimization of current treatment strategies and provide directions for future research aimed at improving survival and quality of life in patients with CPM.
Original languageEnglish
Awarding Institution
  • University Medical Center (UMC) Utrecht
Supervisors/Advisors
  • Kranenburg, Onno, Supervisor
  • Borel Rinkes, Inne, Supervisor
  • Boerma, Djemila, Co-supervisor
  • Elias, Sjoerd, Co-supervisor
Award date8 Dec 2026
Publisher
Print ISBNs978-94-6537-854-1
DOIs
Publication statusPublished - 8 Dec 2026

Keywords

  • peritoneal metastases
  • colorectal cancer
  • CRS-HIPEC
  • PIPAC
  • bidirectional therapy
  • ovarian metastases
  • omentum majus
  • pseudomyxoma peritonei

Fingerprint

Dive into the research topics of 'Clinical and experimental studies on colorectal peritoneal metastases'. Together they form a unique fingerprint.

Cite this